- Approval Id
- b2ad31f92237c803
- Drug Name
- CANESPRO ONCE DAILY CREAM 1%
- Product Name
- CANESPRO ONCE DAILY CREAM 1%
- Approval Number
- SIN15415P
- Approval Date
- 2018-02-01
- Registrant
- BAYER (SOUTH EAST ASIA) PTE LTD
- Licence Holder
- BAYER (SOUTH EAST ASIA) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- General Sale List
- Dosage Form
- CREAM
- Dosage
- <p><strong>Dosage & application</strong><br>
Posology<br>
To achieve a lasting cure, treatment with bifonazole must be carried out reliably and over an adequate period. The usual periods of treatment are summarized in the table below:</p>
<img src="/TGIF/Canespro-Table1.png" alt="Canespro Dosage Table 1" /><br><br>
<p><strong>Method of administration</strong><br>
Once a day, preferably in the evening, before going to bed. It should be applied thinly to the affected skin area and rubbed in. A small amount of cream is generally sufficient to treat an area of about the size of the palm of hand.</p>
<p><strong>Use in Children</strong><br>
No in-depth studies have been performed in the pediatric population (0 to 18 years). From a survey of the clinical data reported there is no indication that harmful effects should be anticipated in pediatric population. However, in neonates (0 to 27 days), infants and toddlers (28 days to 23 months), the medicinal product should only be used under medical supervision.</p>
- Route Of Administration
- TOPICAL
- Indication Info
- <p><strong>Indications</strong></p>
<ul>
<li>Treatment of skin mycoses caused by dermatophytes, yeasts, moulds, and other fungi (e.g. athlete's foot, fungal infection of the hand, ringworms, jock itch, white spots, superficial fungal skin infections & other tinea conditions).</li>
<li>Treatment of erythrasma (skin redness).</li>
</ul>
- Contraindications
- <p><strong>Contraindication</strong><br>
Hypersensitivity to the active substance or to any of the excipients.</p>
- Atc Code
- D01AC10
- Atc Item Name
- bifonazole
- Pharma Manufacturer Name
- BAYER (SOUTH EAST ASIA) PTE LTD
